Massachusetts S 2035: An Act to eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

Status: Accompanied a study order, see H5596 (as of 2026-07-23)

State: Massachusetts · Session: 194th · Bill: S 2035

Sponsors: Jason M. Lewis, Rebecca L. Rausch

View Massachusetts S 2035 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.